How could genetics influence endometriosis treatment?

Genetics may change endometriosis treatment by helping us understand the biological pathways that drive pain, inflammation, and lesion behavior. As those pathways become clearer, researchers can develop more targeted, potentially non-hormonal medications designed for specific mechanisms rather than one-size-fits-all symptom control.

In the near term, the biggest impact is likely improved risk stratification and biomarker development—tools that could help predict who is more likely to have endometriosis, how aggressive it may be, or which approaches might be most effective. Most genetics-guided “precision” treatments are still in development, but our team stays closely aligned with this research and can discuss what’s realistic now versus what may be on the horizon when you meet with us.